Skip to main content

Table 2 Standardized difference scores pre- and post-adjustment in SGLT2i

From: Comparison of kidney and hepatic outcomes among sodium-glucose cotransporter-2 inhibitors: a retrospective study using multiple propensity scores

 

|Std diff|

Adjusted |Std diff|

Age

0.358

0.217

Sex

0.071

0.094

Height

0.059

0.040

Weight

0.137

0.017

BMI

0.139

0.014

Diabetes duration

0.152

0.118

DPP4i

0.083

0.026

SU

0.092

0.046

α-GI

0.218

0.041

GL

0.088

0.025

BG

0.072

0.050

TZ

0.062

0.048

Liver disease

0.096

0.050

Renal disease

0.080

0.023

Heart disease

0.116

0.023

Cerebrovascular disease

0.219

0.078

Hypertension

0.109

0.059

Dyslipidemia

0.167

0.027

HbA1c

0.123

0.009

eGFR

0.077

0.029

AST

0.016

0.013

ALT

0.051

0.013

HDL-C

0.110

0.018

LDL-C

0.063

0.053

TG

0.077

0.014

  1. Std diff Standardized difference scores, BMI Body mass index, DPP-4i Dipeptidyl peptidase-4 inhibitor, SU Sulfonylurea, GL Glinide, α-GI α-glucosidase inhibitor, BG Biguanide, TZ Thiazolidinediones, HbA1c Glycated hemoglobin, eGFR Estimated glomerular filtration rate, AST Aspartate aminotransferase, ALT Alanine aminotransferase, HDL-C High-density lipoprotein-cholesterol, LDL-C Low-density lipoprotein-cholesterol, TG Triglyceride